Background/Aims: The hepatitis B virus X protein (HBx) is a viral trans-activator that plays a crucial role in pathogenesis of hepatocellular carcinoma (HCC) via an unknown mechanism. The role of HBx in modulating cell proliferation and programmed cell death is replete with controversies. Thus, the goal of this study was to elucidate the effect of HBx and its deletion mutants on cell cycle progression in human hepatoma cells. Methods: Huh7 cells transfected with either full-length or truncated HBx were tested for their mitogenic potential based on their effect on the expression of key cell cycle-related proteins (p27, cyclin D1, p21, and p53) and pro-apoptotic proteins such as cleaved poly (ADP-ribose) polymerase (PARP) and Bax. Western blotting and immunofluorescence techniques were applied to detect changes in the expression levels and intracellular localization, respectively, of the investigated proteins. Also, Quantitative real-time PCR (qRT-PCR) was used to detect changes in RNA levels. Results: An increased anchorage-independent growth of cells transfected with HBx-WT and its deletion mutants was observed. The cell cycle regulatory molecules were differentially modulated by full-length HBx (1-154) and its different N-and C-terminal truncated forms (HBx (31-154), HBx (61-154), ). An enhanced modulation of p27, p21, and cyclin D1 was associated with HBx (1-154), whereas p53 expression was significantly inhibited by . Similarly, the expression of cleaved PARP and Bax was efficiently suppressed by HBx (1-94) and . Conclusion: The HBx-WT and its mutants play a critical role in the pathogenesis and progression of HCC by modulating cell cycle regulatory proteins.
Introduction
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the second leading cause of cancer-related deaths in the world [1] . Approximately 50% of HCC cases worldwide are related to hepatitis B virus (HBV) [2] . In chronic HBV carriers, risk of HCC is increased by 5-to 15-fold [3] . Currently, more than 2 billion people have been infected with HBV at some time in their lives, and approximately 240 million people remain chronically infected [4] .
HBV is the prototype member of the family Hepadnaviridae. The genome of HBV consists of a 3.2-kb relaxed circular partially double-stranded DNA. HBx is a 17-kDa regulatory protein consisting of 154 amino acids. HBx is a promiscuous trans-activator that modulates both viral and cellular promoters through a direct interaction with nuclear transcription factors or via cytoplasmic signal transduction [5] . The protein is shown to affect several cellular processes including reduction of adhesion of podocytes [6] , modulation of apoptosis in kidney cell [7] and downregulation of microRNA-145 in HCC [8] . HBx affects cell cycle progression by inducing different signaling pathways, deregulating cell cycle checkpoints, and by protein degradation. In some established cell lines, HBx induces cell cycle progression via downregulation of cell cycle inhibitor proteins such as p21 and p27, and activation of cell cycle promoters such as cyclins D1, E, and cell division cycle 2 (CDC2) kinases [9] [10] [11] . Previous studies have reported inhibition of cell cycle progression by HBx via decreased expression of cyclins D1, E, A, and B1, cyclin-dependent kinase (CDK) 2 and 4, and G2/M phase arrest by activation of cyclin B1-CDK1 [11, 12] . Some studies have reported suppression of apoptosis by HBx through activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), cAMP response element-binding protein (CREB) and phosphatidylinositol 3-kinase (PI3K) pathways, and survivin protein [13] [14] [15] . Other studies have shown that HBx induces apoptosis by activation of caspases and c-Jun amino-terminal kinase (JNK) pathway [11, 16] .
Integration of HBV genomic DNA into cellular chromosomes has been observed in approximately 80-90% of HBV-related HCC, suggesting an important role of viral integration in hepatocellular carcinogenesis [17] . Truncated HBx proteins have different functional properties from those of HBx wild-type [5, 18] , and some studies have suggested that truncated forms of HBx are more prevalent in HBV-associated tumors compared to adjacent non-tumor tissue [19, 20] . Truncated HBx proteins are incapable of promoting apoptosis but able to promote cell proliferation [20, 21] . The study conducted by Kwun et al. have reported differential effects of HBx variants on cell cycle progression depending on their potential to regulate p21 expression [22] .
The aim of this study is to gain additional insight into the pleiotropic behavior of HBx and its role in hepatocarcinogenesis, we generated random variants of HBx and examined their effects on the regulation of cell cycle and apoptosis in hepatoma cell line. We used full-length HBx and four HBx truncated mutants to investigate their modulatory effect on the expression of cell cycle-related proteins (p27, p21, p53, and cyclin D1) and proapoptotic proteins (cleaved poly(ADP-ribose) polymerase (PARP) and Bax) in transfected hepatocarcinoma Huh7 cells.
Materials and Methods
HBV DNA extraction DNA was extracted from serum of one of the patients who was diagnosed with HBV (genotype D1) using Q1Amp MinElute Virus Spin kit (Qiagen, Hilden, Germany) and the extraction procedures were according to the manufacturer's instructions. The complete HBx (465 bp) was amplified by nested-PCR and the PCR conditions were as follows: 95°C for 10 min, followed by 40 cycles at 94°C for 1 min, 62°C for 45 sec, and 72°C for 1 min, with final elongation at 72°C for 7 min. Primer sequences used for amplification of HBx and its mutants are given in Table 1 .
Plasmids
The amplified PCR product of HBx was cloned into pDrive Cloning Vector using PCR cloning kit (Qiagen). The full length HBx (1-154) and its mutants (HBx (31-154) with N-terminal deletion from amino acid 1 to 30, HBx (61-154) with N-terminal deletion from amino acid 1 to 60, HBx (1-94) with a 60-amino acid C-terminal deletion, HBx (61-124) with N-terminal deletion from amino acid 1 to 60 and a 30-amino acid C-terminal deletion, and HBx (Δ31-90) with a 60-amino acid internal deletion from amino acid 31 to 90 were amplified from the above constructed clone by PCR, using specific primers (Table 1) containing EcoRI restriction site. This site matched that is found in the PEGFP-C1 vector (Clontech, Mountain View, CA, USA), which was used to create new HBx-expressing recombinant plasmids by ligation using Quick T4 DNA ligase (New England Biolabs).
Cell culture and transfection
The human hepatocarcinoma cell line Huh7 was cultured in Dulbecco's modified Eagle's medium supplemented with 10% of fetal bovine serum and 1% of antibiotic mixed solution (penicillin-streptomycin) (Invitrogen, Carlsbad, CA, USA) in 5% CO 2 at 37°C. Huh7 cells were transfected with empty PEGFP-C1 vector, GFP/HBx wild-type, and GFP/HBx mutants using Lipofectamine 2000 (Invitrogen), according to the manufacturer's instructions. Empty PEGFP-C1 vector without HBx was used as control. Expression of HBx in transfected cells was verified by Western blot analysis.
Cell transformation assay
CytoSelect 96-well Cell Transformation Assay Kit (Cell Biolabs, San Diego, CA, USA) was used to assess the tumorigenic potential of HBx and its mutants based on anchorage-independent cell growth in soft agar. In brief, Huh7 cells transfected with different HBx deletion mutants were plated on soft agar in a 96-well plate and incubated for 6-8 days before being solubilized, lysed, and detected by the CyQuant® GR Dye (Molecular Probes, Eugene, OR, USA) using a fluorescence plate reader (Anthos Zenyth 3100) with an excitation wavelength of 485 nm and an emission wavelength of 530 nm. The anchorage-independent cell growth was determined according to the protocol provided by the manufacturer.
Western blotting
Total protein was extracted from transfected cells using radioimmunoprecipitation assay (RIPA) lysis buffer (Sigma-Aldrich, St. Louis, MO, USA). Total protein content was determined using the Bradford assay kit (Bio-Rad, Hercules, CA, USA) according to the manufacturer's instructions at 595 nm. For Western blot analysis, equal amount of protein samples were separated by 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore, Billerica, MA, USA). Blots were blocked with 5% skim milk, followed by incubation with rabbit antibodies against HBx (GenScript USA Inc., Piscataway, NJ, USA), p27, cyclin D1, p53, p21, cleaved PARP and Bax (Santa Cruz Biotechnology, Dallas, TX, USA), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Cell Signaling Technology, Danvers, MA, USA). Blots were incubated with secondary antibody conjugated to horseradish peroxidase and visualized by SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific, Waltham, MA, USA). 
Statistical analysis
Bands in the Western blot images were quantified by Image J software (NIH Image, NIH Bethesda, USA). Calculation was performed by subtracting the background intensity from intensity of the band of interest. Each measurement was repeated in at least three independent experiments. The data was assessed as means ± standard deviation (SD) and the student's t-test was used to assess the differences between means. P values <0.05 were considered to be statistically significant. All statistical analyses were performed using Statistical Package for Social Sciences (SPSS) software (version 16, SPSS, Inc, Chicago, IL, USA). GFP/HBx fusion proteins were mainly localized in the cytoplasm except the mutant GFP/ HBx (61-124), largely found in the nucleus (Fig. 1C) .
Results

Construction and expression of HBx mutants
Effect on anchorage-independent cell growth and apoptosis
The tumorigenic potential of the different HBx deletion mutants was estimated by cell transformation assay. The soft agar colony formation assay showed an increased colony formation in GFP/HBx wild-type compared to the empty PEGFP-C1 vector and untransfected Huh7 cells (Fig. 2) . This increased anchorage-independent growth observed in cells transfected with HBx (1-154) was statistically significant (p = 0.002) as compared to the empty PEGFP-C1 vector and untransfected Huh7 cells (Fig. 2) . The cells transfected with the HBx mutant constructs showed a range of variation in tumorigenic potential compared to HBx (1-154) . The tumorigenicity of all the investigated HBx deletion mutants was less than that of HBx (1-154). HBx loss its tumorigenic effect by ~80-90% after deletion of 60 aa (Δ31-90) while the constructs HBx (61-124) and HBx (1-94) decrease by ~50% HBX tumorigenic effects. No significant variation in tumorigenic potential was observed for HBx and HBx (61-154). These results emphasize different possible mechanisms by which HBx and its mutants influence the cell cycle progression.
Effect on cell cycle regulators p27 and p21, two important members of the CDK interacting protein/kinase inhibitory protein (CIP/KIP) family, are cell cycle inhibitors blocking G1/S phase transition [23] . HBx (1-154) significantly decreased the expression of p27 compared to the control vector (Fig.  3A) . HBx (61-154) and HBx (61-124) were less efficient in downregulating the expression of p27 compared to HBx (1-154). HBx (31-154) and HBx (1-94) did not show any significant effect on expression of p27 compared to HBx (1-154). HBx (61-154) and HBx (61-124) showed decreased ability to modulate p27 expression, whereas HBx (31-154) did not show any significant effect, suggesting that amino acids 31-60 are important for p27 expression regulation. Therefore, the degree of regulation of p27 expression by HBx (Δ31-90) was examined. HBx (Δ31-90) showed similar results as HBx (61-154) and HBx (61-124) in regulating p27, supporting the role of amino acids 31-60 in the inhibitory activity of HBx (Fig. 3A) . p21 expression was the most strongly downregulated protein by HBx and its (Fig. 3B) . Cyclin D1-CDK4 complex is active during G1 phase and has a key role in cell cycle progression. Cyclin D1 was significantly upregulated by HBx (1-154) compared to the control vector. All the truncated HBx mutants significantly decreased the expression of cyclin D1 compered to both HBx (1-154) and the control vector (Fig. 3C) .
Effect on p53
p53 is a tumor suppressor protein responsible for induction of apoptosis or cell cycle arrest at the G1/S transition checkpoint [24] . HBx (1-154) decreased the expression of p53 compared to the control vector (Fig. 4) . HBx (31-154) and(1-94) decreased the expression of p53 to a lesser degree than HBx (1-154). HBx (61-154) and HBx (61-124) decreased the expression of p53 to a larger extent than HBx (1-154). HBx (61-124) with a truncation at both N-and C-terminus was the most efficient in downregulating p53 expression (Fig. 4) .
Effect on apoptotic mediators
HBx is known to regulate apoptosis by modulating the expression of pro-and antiapoptotic proteins [5] . HBx (1-154), HBx (31-154), and HBx (61-154) inhibited the generated cleaved PARP when compared to the control vector (Fig. 5A) . HBx (61-124) showed the most effective inhibition of PARP cleavage compared to HBx (1-154) . Similarly, HBx (1-154) also suppressed the expression of pro-apoptotic factor Bax (Fig. 5B) . HBx (31-154) and HBx (61- (Fig. 5B) .
Discussion
HBx is an HBV regulatory protein known to exert influence over a broad range of host cell functions like cell cycle progression, signaling pathways, and gene expression, contributing to oncogenic processes in HBV-related HCCs [5] . Several studies have suggested that HBx or its mutants are the most commonly integrated and preferentially expressed HBV genes [5, 17, 25, 26] . Most studies have proposed that full-length HBx has two functional domains, N-and C-terminus, but there is less consensus on the regulatory role played by each domain [5, 20, 27, 28] . Any deletion in the full-length HBx might alter the balance of the functional domains in regulation of cell proliferation, apoptosis, transactivation, transformation, and protein-protein interaction. This study investigated the tumorigenic potential of different HBx mutants compared to full-length HBx and identified the related changes in expression of various effector molecules involved in cell cycle progression and apoptosis. The clinical implications of such studies will bring significant increase in the effect of HBx-targeting therapeutic methods by controlling the cell cycle disrupting activities of HBx or its mutants.
In the present study, full-length HBx (1-154) and its mutants HBx (31-154), HBx (61-154), HBx (1-94) were found mainly localized in cytoplasm. This result was consistent with previous studies which reported cytoplasmic localization of HBx, especially at high expression levels of the protein frequently observed in transient transfections [5] . Truncation at either the N-or the C-terminus did not control the cellular localization of HBx, consistent with previous studies [29, 30] . One of the interesting findings in this study was that the double truncation mutant HBx (61-124) with a 60-amino acid deletion at the N-terminus and a 30-amino acid deletion at the C-terminus was found mainly in the nucleus. Some studies have reported that amino acid residues in different domains of HBx are prone to phosphorylation and other post-translational modifications, and these modifications might regulate cellular localization of HBx [31, 32] . The possible reason for nuclear localization of HBx (61-124) could be that truncation at both ends might result in a conformational change in the protein either exposing a masked nuclear localization signal or increasing the possible surface accessibility of the amino acid residues for post-translational modifications and interactions with cellular proteins capable of changing the cellular localization. Alefantis et al. have reported that the localization of human T-cell leukemia virus type 1 (HTLV-1) trans-activator protein Tax was directed by specific changes in Tax or by its interactions with cellular proteins [33] .
HBx causes uncontrolled cell proliferation by deregulating cell cycle checkpoints via altered expression or proteolytic degradation of cyclin-dependent kinase inhibitors [5, 10] . The cell cycle regulators p27 and p21 are active in G1 phase but block G1/S phase transition by binding and inhibiting the cyclin E-cdk2 complex [22, 34, 35] . Mukherji et al. have reported the early proteolytic degradation of cdk2-bound p27 mediated by cdk2 phosphorylation of p27 in the presence of HBx [10] . Cdk2 has been reported to interact weakly with amino acids 58-84 of HBx but is associated with specific phosphorylation of serine-rich domain (amino acids 21-57) of HBx. In this study, HBx (61-154) and HBx (61-124) led to increased activity of HBx in modulating p27 as compared to that of HBx . This decreased activity of HBx mutants might be due to disruption of the phosphorylation site within the deleted amino acids 31-60. HBx (Δ31-90) also showed a decrease in HBx activity. Since HBx lacks the consensus cdk2 recognition motifs, our results suggest that exclusive phosphorylation of serine-rich domain plays a role in modulating HBx effect on p27 destabilization. Several different studies have reported downregulation as well as upregulation of p21 expression by HBx [11, 36, 37] . The results of the present study showed that full-length HBx and all its truncated forms significantly downregulated p21 expression with almost similar efficiency. Although other factors have been suggested to regulate p21 expression [22, 23, 31, 35, 36, 38, 39] , we showed that HBx downregulated the expression of p53, and this resulted in inhibition of downstream p21 expression by all forms of HBx, suggesting that p21 expression is highly dependent on p53. This is consistent with the reports of p53-dependent regulation of p21 expression in other viruses like human papillomavirus and hepatitis C virus [35] .
In the present study, p53 was downregulated by full-length HBx and all its truncated forms to a variable degree. HBx (61-124) included amino acids 58-119, known to be essential for signal transduction [40] , while the absence of modulating N-and C-terminal regions might be responsible for its enhanced activity in downregulation of p53. Lee [41] . As HBx is known to induce c-Myc expression [42] , the observed downregulation of p53 in the present study might be due to increased binding of Myc to the p53 promoter. HBx has a controversial role in modulation of apoptosis: some studies have showed proapoptotic effects [43] [44] [45] [46] [47] , while others have assigned an anti-apoptotic effect with a role in HCC [48] [49] [50] [51] [52] . Caspase 3 is a cysteine-aspartate protease responsible for cleaving various substrates, including PARP, which leads to cell apoptosis. HBx has been reported to inhibit caspase 3 activity [53] . Our results indicate that HBx (1-154), HBx (31-154), and HBx (61-154) had similar inhibitory effect on expression of cleaved PARP, whereas HBx (61-124) showed significant increase in the inhibition of cleaved PARP. This was partially in agreement with Gottlob et al. that have shown that a deletion of 1-50 amino acids at the N-terminus did not have any effect on the inhibition of caspase activity [53] . Our results showed a reduction in the inhibition of caspase activity in C-terminal deletion mutants of HBx. HBx inhibits p53-mediated upregulation of Fas, which has been shown to activate caspase 3 activity [54, 55] . Our observation that p53 expression was strongly suppressed by HBx (61-154) and HBx (61-124) supported the increased inhibition of cleaved PARP expression by these mutants possibly via downregulation of Fas-mediated caspase 3 activity. Similar to our results, Tu et al. have reported that both natural and artificial mutants of HBx with a C-terminal deletion caused suppression of pro-apoptotic function [20] . Bax, a pro-apoptotic protein member of the Bcl-2 family, participates in the induction of apoptosis in response to many apoptotic signals. Also for Bax expression, the C-terminal deletion caused a suppression of proapoptotic effect of HBx, leading to an increased inhibition of Bax by HBx (31-154) and HBx (61-254).
The role of HBx in cell regulation and pathogenesis of hepatocellular carcinoma is replete with controversial and contradictory studies. In the present study, we evaluated the effect of HBx and its truncated forms directly on the expression of specific cell cycle regulators. We observed that each cell cycle regulator molecule had a distinct pattern of response to different HBx forms. p27, p21, cyclin D1, p53, pro-apoptotic cleaved PARP, and Bax were better modulated by HBx (1-154), HBx (61-124), HBx (1-94), and HBx (61-124), respectively. One of the possible explanation for the reported pleiotropic effect of HBx on cellular regulation could be the co-existence of different forms of the HBx, as reported previously by Tu et al. [20] , and a specific effect on the expression of effector molecules exerted by each HBx form. The combined effect on cellular regulation could also depend on the relative proportion of each mutant form and how efficiently the expression of regulatory proteins is modulated by HBx. The tumorigenic potential of different HBx mutants was assessed in-vitro by their ability to initiate uncontrolled growth in cells. The reduction in tumorigenic potential of HBx (Δ31-90) supported the observed decreased activity of this mutant in modulating p27 in the present study. As shown by cell transformation assay, the tumorigenic potential of the full-length HBx is greater than that of the C-terminal deletion mutants, which appears to be contradictory to other results in this study. This could be explained considering that the C-terminal region spanning amino acids 141-154 decreases HBx stability [56] . The HBx C-terminal deletion mutants in HBV-infected cells have an increased stability compared to the full-length HBx and might play a more active role in the development of HCC. Our results are consistent with the previous reports of C-terminal deletion mutants promoting cell proliferation [28, 57] . This is further supported by several studies demonstrating the increased frequency of C-terminal deletions of HBx in the genome of HBV-associated liver tumor cells [29] .
Conclusion
Direct effect of full-length HBx and its truncated forms on the expression of effector molecules of cell cycle progression was observed. C-terminal deletions increased the Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry
